Lab Research Equipment Stock
Pressure Biosciences, Inc. (PBIO)
on Investing News Show
Live Interview with Richard Schumacher,
President, Chief Executive Officer and Director of
Laboratory Instrument Stock Pressure Biosciences, Inc.
Featuring pressure cycling technology laboratory instrumentation equipment company.
Pressure Biosciences, Inc.
(Stock Symbol: PBIO)
Watch a replay of the interview:
See corporate site: PressureBiosciences.com
Get PBIO Stock Quote
See Latest Company Press Releases
Watch a replay of the full show:
Mr. Schumacher discusses the latest PBIO news:
Considered Among the Most Prestigious Recognitions of Invention and Innovation Worldwide, the R&D 100 Awards Identify the Top 100 Revolutionary Technologies of the Past Year
Lab Instruments Medical Products Stock
Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market.
Products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure.
PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 275 PCT systems in approximately 160 sites worldwide.
There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.
PBIO primary application development and sales efforts are in the biomarker discovery and forensics areas.
Customers also use PBIO products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications.
See Pressure BioSciences Life Sciences Lab Instruments Products Page
To date, PBIO has installed over 250 PCT systems in approximately 160 sites worldwide.
Richard T. Schumacher
President, Chief Executive Officer and Director
Mr. Richard T. Schumacher, the founder of our Company, has served as a director of Pressure BioSciences since the formation of its legacy business, Boston Biomedica, Inc., in 1978. He has served as CEO of Pressure BioSciences since April 2004 and President since September, 2004.
He previously served as CEO and Chairman of the Board of Boston Biomedica from 1992 to February, 2003 and as President from 1986 to August 1999. Mr. Schumacher served as the Director of Infectious Disease Services for Clinical Sciences Laboratory, a New England-based medical reference laboratory, from 1986 to 1988. From 1972 to 1985, Mr. Schumacher was employed by the Center for Blood Research, a nonprofit medical research institute associated with Harvard Medical School. Mr. Schumacher received a BS in Zoology from the University of New Hampshire.
Investment News Show
Money Info Show Airs
10 AM to 11 AM EDT
Every Tuesday
LISTEN LIVE
Use this Link To Watch The Show:
www.princetonresearch.com/money-info-live.htm
Be On The Air With Us
Call In Your Questions
888-792-1590
Money Info
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
The show is broadcast live on the internet and on the air from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast
Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.